AT258920B - Verfahren zur Herstellung von neuen substituierten Piperazinderivaten - Google Patents

Verfahren zur Herstellung von neuen substituierten Piperazinderivaten

Info

Publication number
AT258920B
AT258920B AT1043865A AT1043865A AT258920B AT 258920 B AT258920 B AT 258920B AT 1043865 A AT1043865 A AT 1043865A AT 1043865 A AT1043865 A AT 1043865A AT 258920 B AT258920 B AT 258920B
Authority
AT
Austria
Prior art keywords
preparation
piperazine derivatives
substituted piperazine
new substituted
new
Prior art date
Application number
AT1043865A
Other languages
English (en)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of AT258920B publication Critical patent/AT258920B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT1043865A 1963-04-04 1963-09-03 Verfahren zur Herstellung von neuen substituierten Piperazinderivaten AT258920B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27053463A 1963-04-04 1963-04-04
US27053663A 1963-04-04 1963-04-04
US27053763A 1963-04-04 1963-04-04

Publications (1)

Publication Number Publication Date
AT258920B true AT258920B (de) 1967-12-27

Family

ID=27402296

Family Applications (2)

Application Number Title Priority Date Filing Date
AT1043865A AT258920B (de) 1963-04-04 1963-09-03 Verfahren zur Herstellung von neuen substituierten Piperazinderivaten
AT710663A AT258911B (de) 1963-04-04 1963-09-03 Verfahren zur Herstellung von neuen Piperazinderivaten

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT710663A AT258911B (de) 1963-04-04 1963-09-03 Verfahren zur Herstellung von neuen Piperazinderivaten

Country Status (6)

Country Link
AT (2) AT258920B (de)
DE (1) DE1445457A1 (de)
DK (2) DK108674C (de)
ES (1) ES291187A1 (de)
FR (2) FR1528557A (de)
GB (1) GB1067817A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452798A (en) * 1982-06-22 1984-06-05 Warner-Lambert Company 1-Substituted phenyl-4-alkyl hydantoin piperazine compounds as antihypertensive agents
GB8619472D0 (en) * 1986-08-09 1986-09-17 Pfizer Ltd Anti-arrhythmia agents
GB9826412D0 (en) * 1998-12-03 1999-01-27 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
DE1445457A1 (de) 1969-01-02
DK108576C (da) 1968-01-08
GB1067817A (en) 1967-05-03
DK108674C (da) 1968-01-29
AT258911B (de) 1967-12-27
FR1528557A (fr) 1968-06-14
FR94701E (fr) 1969-10-24
ES291187A1 (es) 1964-01-16

Similar Documents

Publication Publication Date Title
AT255421B (de) Verfahren zur Herstellung von neuen Pyrimidinderivaten
CH451200A (de) Verfahren zur Herstellung von neuen Bis-alkanolaminderivaten
CH482648A (de) Verfahren zur Herstellung von neuen Phenylzyklopropanverbindungen
CH451201A (de) Verfahren zur Herstellung von neuen Phenylalkanolaminderivaten
AT240376B (de) Verfahren zur Herstellung von neuen 4-Aza-thioxanthen-Derivaten
CH426873A (de) Verfahren zur Herstellung von neuen Thiepinderivaten
AT258920B (de) Verfahren zur Herstellung von neuen substituierten Piperazinderivaten
AT247347B (de) Verfahren zur Herstellung von neuen Piperazinverbindungen
AT253492B (de) Verfahren zur Herstellung von neuen Äthanoanthracenderivaten
CH444165A (de) Verfahren zur Herstellung von Piperazinderivaten
CH422000A (de) Verfahren zur Herstellung von neuen Thiepinderivaten
CH419175A (de) Verfahren zur Herstellung von neuen Thiepinderivaten
AT254190B (de) Verfahren zur Herstellung von neuen Chinolinderivaten
AT242130B (de) Verfahren zur Herstellung von neuen Nitrofuryl-Derivaten
AT246131B (de) Verfahren zur Herstellung von neuen 5-Hydrazino-pyrazol-Derivaten
AT246338B (de) Verfahren zur Herstellung von neuen Derivaten der Primulasäure
CH490335A (de) Verfahren zur Herstellung von neuen Phenylzyklopropanverbindungen
CH457418A (de) Verfahren zur Herstellung von neuen 17B-Acetoacetoxysteroiden
AT250943B (de) Verfahren zur Herstellung von neuen 5-Nitropyrrolderivaten
AT240375B (de) Verfahren zur Herstellung von neuen 1-Aza-thioxanthen-Derivaten
AT247322B (de) Verfahren zur Herstellung von neuen Thieno-benzothiapyran-Derivaten
AT255420B (de) Verfahren zur Herstellung von neuen Piperidinderivaten
AT247328B (de) Verfahren zur Herstellung von neuen Piperidinderivaten
AT250361B (de) Verfahren zur Herstellung von neuen Piperidinderivaten
CH436309A (de) Verfahren zur Herstellung von Piperazinderivaten